Stoma patency device for hydrocephalus treatment
Year
2023
Project team
Ellen Roche with Luca Rosalia, Sarah Sams, Bryce Starr, Jonas Sogbadji and Gabriel Friedman
![](https://deshpande-mit-edu.ezproxyberklee.flo.org/wp-content/uploads/2023/08/AdobeStock_208293857-scaled-aspect-ratio-580-360-scaled-580x360-c-default.jpg)
2.45 million
global cases of hydrocephalus annually
Two
surgical procedures to manage condition
Current
treatments have limitations
Creating a new standard of care
Hydrocephalus results from excess of cerebrospinal fluid within the brain and can cause symptoms ranging from headaches to seizures, and can have long-term impact on patients and their families. Surgical management is necessary. The current standard of care involves placement of a subcutaneous catheter; however, it is more invasive and carries a higher complication rate. A growing alternate procedure, endoscopic third ventriculostomy (ETV), creates a stoma in the brain and is less invasive, but is hindered by stoma closure rates. This team is developing an endoscopically, self-deployable device to keep the stoma open. That would help neurosurgeons establish ETV stenting as the standard of care for patients with hydrocephalus.